Vital Chemtech Ltd

Vital Chemtech Ltd

₹ 77.1 1.31%
22 Nov - close price
About

Incorporated in 2014, Vital Chemtech Ltd manufactures and supplies phosphorous based chemicals[1]

Key Points

Business Overview:[1][2]
VCL is a part of Vital Group which is a multi-product organization involved in Manufacturing, Contract Manufacturing and Exports of Chemicals. Company does manufacturing and supplying of Phosphorus Derivatives Products and Phosphorus base chemicals. It also does trading of its raw Material and is in the process of obtaining approval of Phosphorus Pentasulfide (P2S5)

  • Market Cap 185 Cr.
  • Current Price 77.1
  • High / Low 115 / 67.0
  • Stock P/E 37.4
  • Book Value 38.5
  • Dividend Yield 0.65 %
  • ROCE 5.60 %
  • ROE 4.05 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Earnings include an other income of Rs.2.94 Cr.
  • Company has high debtors of 156 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
52 58 61 56 50 52 61
44 46 51 51 48 49 57
Operating Profit 8 12 9 6 2 3 4
OPM % 16% 20% 15% 10% 4% 6% 6%
0 0 0 -0 2 2 1
Interest 0 0 0 1 0 1 0
Depreciation 1 1 1 1 1 1 1
Profit before tax 7 11 8 4 2 3 4
Tax % 34% 26% 23% 45% 14% 21% 23%
5 8 6 2 2 2 3
EPS in Rs 11.75 3.46 0.82 0.78 0.91 1.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 5m Mar 2023 Mar 2024 TTM
41 47 58 117 102 113
37 41 46 102 97 106
Operating Profit 4 6 12 15 5 7
OPM % 10% 14% 20% 13% 5% 6%
0 0 0 0 3 3
Interest 1 1 0 1 1 1
Depreciation 1 1 1 2 2 2
Profit before tax 2 5 11 11 5 6
Tax % 55% 38% 26% 30% 18%
1 3 8 8 4 5
EPS in Rs 11.75 3.36 1.68 2.07
Dividend Payout % 0% 0% 0% 15% 30%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 29%
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 7%
TTM: 29%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -15%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 7 24 24 24
Reserves 8 66 66 68
36 24 13 5
30 17 24 31
Total Liabilities 81 131 126 128
17 19 19 19
CWIP 0 0 0 0
Investments 3 15 34 27
61 96 73 82
Total Assets 81 131 126 128

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-13 -10 15
1 -20 -28
18 53 -16
Net Cash Flow 6 23 -29

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 264 120 156
Inventory Days 87 57 59
Days Payable 265 57 106
Cash Conversion Cycle 87 120 109
Working Capital Days 153 139 123
ROCE % 15% 6%

Shareholding Pattern

Numbers in percentages

Nov 2022Mar 2023Sep 2023Mar 2024Sep 2024
73.28% 73.43% 73.43% 73.43% 73.43%
6.53% 3.62% 0.78% 0.56% 0.16%
4.12% 1.81% 0.96% 0.33% 0.25%
16.07% 21.14% 24.83% 25.68% 26.16%
No. of Shareholders 2,2841,8792,2762,3202,432

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents